Nivolumab (Anti-PD-1 antibody; ONO-4538/BMS-936558) in renal cancer
Ozono, S.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(9): 1077-1080
2014
ISSN/ISBN: 0385-0684 PMID: 25248891 Document Number: 674133
The effect of the anti-PD-1 antibody, nivolumab (ONO-4538/BMS-936558) on advanced renal cancer is promising. The present manuscript summarizes the use of this new drug in immunotherapy for renal cancer.
Document emailed within 1 workday
Related Documents
Mitsui, K.; Taki, T.; Miyagawa, Y.; Yamada, Y.; Honda, N.; Fukatsu, H.; Yoshikawa, K.; Segawa, A. 1995: Scintigraphic detection of xenografted renal tumor by anti-renal cancer monoclonal antibody radiolabeled with technetium-99m Hinyokika Kiyo. Acta Urologica Japonica 41(8): 593-601Lee, C.H.; Suh, C.H.; Lee, J.; Kim, Y.T.; Lee, S.K. 2003: The effects of anti-idiotypic antibody on antibody production and apoptosis of anti-dsDNA antibody producing cells Clinical and Experimental Rheumatology 21(3): 291-300
Chakraborty, M.; Mukerjee, S.; Foon, K.A.; Köhler, H.; Ceriani, R.L.; Bhattacharya-Chatterjee, M. 1995: Induction of human breast cancer-specific antibody responses in cynomolgus monkeys by a murine monoclonal anti-idiotype antibody Cancer Research 55(7): 1525-1530
Almogren, A. 2010: Anti-double stranded antibody. Association with titers and fluorescence patterns of anti-nuclear antibody in systemic lupus erythematosus Saudi Medical Journal 31(1): 32-36
Zhang, F.-C.; Liu, L.; Xu, D. 2007: Correlation of anti-60000 SSA antibody and anti-52000 SSA antibody with systemic lupus erythematosus and Sjögren's syndrome Zhonghua Yi Xue Za Zhi 87(1): 7-10
Blottière, H.M.; Douillard, J.Y.; Koprowski, H.; Steplewski, Z. 1990: Immunoglobulin class and immunoglobulin G subclass analysis of human anti-mouse antibody response during monoclonal antibody treatment of cancer patients Cancer Research 50(3 Suppl): 1051s-1054s
Min, D.J.; Kim, S.J.; Park, S.H.; Seo, Y.I.; Kang, H.J.; Kim, W.U.; Cho, C.S.; Kim, H.Y. 2002: Anti-nucleosome antibody: significance in lupus patients lacking anti-double-stranded DNA antibody Clinical and Experimental Rheumatology 20(1): 13-18
Maeda, T.; Nomoto, K. 1995: Anti-T cell receptor antibody treatment of mice with lupus-like graft versus host disease: suppression of glomerulonephritis without reduction in anti-DNA antibody levels Journal of Rheumatology 22(12): 2259-2265
Kinoshita, M. 1990: Anti-Jo-1 antibody and anti-aminoacyl-tRNA synthetase antibody as a marker autoantibody for myositis Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 482-484
Tax, W.J.; van de Heijden, H.M.; Willems, H.W.; Hoitsma, A.J.; Berden, J.H.; Capel, P.J.; Koene, R.A. 1987: Immunosuppression with monoclonal anti-T3 antibody (WT32) in renal transplantation Transplantation Proceedings 19(1 Part 3): 1905-1907
Boyce, N.; Holdsworth, S.; Atkins, R.; Dowling, J. 1985: De-novo anti-GBM-antibody-induced glomerulonephritis in a renal transplant Clinical Nephrology 23(3): 148-151
Garovoy, M.R.; Suthanthiran, M.; Gailiunas, P.; Carpenter, C.B.; Graves, M.; Busch, G.; Tilney, N.L. 1978: Anti-Ia antibody eluted from rejected human renal allografts Transplantation Proceedings 10(3): 613-616
Tanaka, K. 2005: Diagnostic tests: Anti-Purkinje cell antibody (Anti-Yo/type 1 antibody) Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 7): 479-482
Lonze, B.E.; Dagher, N.N.; Simpkins, C.E.; Singer, A.L.; Segev, D.L.; Zachary, A.A.; Montgomery, R.A. 2009: The fate of anti-HLA antibody among renal transplantation recipients treated with bortezomib Clinical Transplants 2009: 377-384
Wang, X.H.; Xie, T. 1993: Anti-CD3 and -CD4 monoclonal antibody in the treatment of steroid-resistant renal allograft rejection Chinese Medical Journal 106(11): 821-824
Hayes, J.M.; Spencer, W.; Valenzuela, R.; Caulfield, M.; Novick, A.C. 1989: Immunosuppression with an anti-IL-2 receptor monoclonal antibody in a baboon renal allograft model Transplantation Proceedings 21(1 Part 1): 1006-1009
Tanaka, H.; Waga, S.; Tateyama, T.; Nakahata, T.; Sugimoto, K.; Kakizaki, Y.; Yokoyama, M. 2001: Immunocomplex-mediated crescentic glomerulonephritis associated with anti-DNA antibody: a renal limited lupus? Clinical Nephrology 55(2): 177-179
Kitamura, K. 2005: Duffy blood groups and their antibodies (anti Fy(a) antibody, anti Fy(b) antibody) Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 7): 690-691
Imazeki, H.; Kato, K.; Boku, N. 2019: Nivolumab Treatment for the Patients with Gastric Cancer-Present and Future Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(10): 1513-1523
Zhou, T.; Li, X.; Wu, P.; Zhang, D.; Zhang, M.; Chen, N.; Dong, D. 2000: Effect of anti-P-selectin monoclonal antibody on renal ischemia/reperfusion injury in rats Chinese Medical Journal 113(9): 790-793